CIPN - CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Clinical trials for CIPN - CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new CIPN - CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY trials appear
Sign up with your email to follow new studies for CIPN - CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Squeeze away chemo pain: gloves and socks tested to stop nerve damage
Symptom relief OngoingThis study tests if wearing tight gloves and foot caps during chemotherapy can prevent nerve damage (tingling, numbness, pain) caused by the drug paclitaxel. 182 people with nasopharyngeal cancer will wear the pressurized gear on one hand and foot, while the other side serves as …
Matched conditions: CIPN - CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated May 12, 2026 13:41 UTC
-
Yoga vs. nerve pain: major trial tests Drug-Free relief for cancer survivors
Symptom relief OngoingThis study tests whether yoga can reduce nerve pain (peripheral neuropathy) caused by chemotherapy. About 227 cancer survivors will either take yoga classes, attend educational sessions, or continue their usual care. Researchers will measure pain levels, balance, fall risk, and q…
Matched conditions: CIPN - CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC
-
Can acupuncture ease Chemo's lingering nerve pain?
Symptom relief OngoingThis study tests whether electroacupuncture (a type of acupuncture with mild electric pulses) can reduce nerve pain caused by chemotherapy in cancer survivors. About 255 people who have finished chemo and still have pain, numbness, or tingling in their hands or feet will receive …
Matched conditions: CIPN - CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 06, 2026 16:02 UTC